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OBJECTIVE: To assess, in tde human endometrial cell line HEC-1-A, the presence ofprotein tyrosine
phosphatase 1D (PTP1D.) and the possible requlation of its mRNA expression by mitcVqctis such as
forskolin (an acent that increases intracellular cyclic adenosine monophosphate /cA. M1PI levels), epidernal
growth factor (EGF), and insulin-like growth factor-I (IGF-I,).
METHODS: Cells were grown to conftluence and maintained in serum-free media fir 24 hours before
treatment. Cells w'ere exposed toforskolin, EGF, and IGF-I for increasin-g tine periods (0, 1, 3, 6, atnd
24 hours), and PTP1D mRVA expression wvas determined by JNorthern blot analysis. In addition, tells
were incubated with increasingq doses offorskolin (final concentrations: 1, 5, 10, 20, and 30 >pmrol/L) for
6 hou rs.
RESULTS: W4/hen treated wvith the various initoges, tcells increased their stimulation ofPTP1D mRNA
expression in a time- and dose-dependent fashion. Specifically, firskolin, EGF, and IGF-I induced
maximal mRNJA expression at 6, 3, and 6 hours, respectively. Expression induced by forskolin, EGF, and
1GF-1 was five, three, and six times control levels, respectively. At a dose of 1t0 pmol/L, forskoin induced
PTP1D mRnNA expression almost two times higher than control mt'alies.
CONCLUSION: These data sinweet that in hmuman endometrial carcinomas, cAMP, EGF, and IGF-I
may regjlate the expression of PTP1D mRNA, which may, in turnJ, play a role ini uncontrolled cell
proliferation and neoplastic transformation. ( Soc Gynecol Ifnvet 199'7;4:310-315) Copyrnlit
@ 1997 b)y tie Society for Gynecologic InvestIgation).
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'%,rotein tyrosine phosphatases (PTPases) are a family of
y i cytosolic and transmembrane proteins that participate
in the delicate balance of tyrosine phosphorylation/
dephosphorylation and thus play a role in the regulation of
cell growth, development, and differentiation. Some of these
PTPases act to enhance transduction0 of signals from receptor
tyrosine kinases to the nucleus, whereas others act in a negative
regulatory role.'" One such enzyme, protein tyrosine phos-
phatase 11 (PTPID; also known as Syp, SHPTP2, SHPTIP3,
and PTP2C), is a ubiquitously expressed cytosolic PTPase that
contains two Src homolog-y (SH2) domains at its amino ter-
minus.3-4 These domains have been shown to associate with
the cytoplasmic domains of the epiderrnal growth factor
(EGF), insulin-like growth factor-I (I(.F-I), and platelet-de-
rived growth factor receptors as well as With the intermedi-
ate signaling protein, insulin receptor substrate-i (IRS-i).' In
addition. the activity of PTP1 D has been shown to be ligand
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dependent, requinng phosphorylation oftyrosine residues after
autophosphorylation of tyrosine kinase receptors.4 Although
the role of this PTPase in signal transduction is not understood
completely. niicroinjection of anti-PTP l1) antibody and
GST-SH2 fusion protein into mouse fibroblasts after stimula-
tion with EGF and IGF-T has demonstrated decreased mito-
genesis.' Thus, its role appears to be positive in the signaling
cascade after receptor tyrosine kinase activation.
Previous work from our laboratory has shown that peptide
growth factors and substances that increase intracellular cyclic
adenosine monophosphate (cAMP) levels produce mitogenesis
in the endometrial cell line HEC-1-A.78 Because growth and
proliferation of HEC-1 -A cells are stimulated by forskolin (an
agent that stimulates intracellular cAMl1 levels), EGF, and
ICF-I by tyrosine phosphorylation, the present studies were
conducted to exaniine whether, in endometrial carcinoma,
PTPID iRNA expression is positively linked to the increase
in proliferative activity stinaulated by EGF. IGF-l, and forsko-
lin (cAMP). Our results show that all three mitogens stimulate
the expression of PTPDI imRNA in the endometrial adeno-
carcinoma cell line HEC-I-A.
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MATERIALS AND METHODS
Cell Line Culture and Treatment
The HEC-1-A (HTB-112) cell line was purchased from the
American Type Culture Collection (Rockville, Ml)). The
cells were cultured in 75-cm3 flasks (Becton Dickinson, Lin-
coln Park, NJ) and maintained in Phenol red-free Dulbecco's
nmodified Eagle's medium/HaIl's nutrient mixture Fl 2
(DME/F12; Sigma, St. Louis, MO) supplemented with 10%
fetal bovine serum (FBS), 1.2 g sodium bicarbonate. 50 ,ug/mL
gentamicin, and 2 U/rnL nystatin. The culture medium was
adjusted to pH 7.35 before filtration (Nalgene, Rochester,
NY). Cultures were maintained under sterile conditions at
37C in a humidified environment containing 5% CO. For
experiments, the cells were detached with fresh trypsin
(0.02%)/ethylenediaminetetra-acetic acid for 10 minutes.
Fresh medium was added and the cell suspension was centri-
fuged at 15() X g for 10 minutes. The supernatant was dis-
carded and the cell pellet was resuspended in fresh medium.
Cells were dispensed into 100-nmm tissue culture dishes (Bec-
ton lDickinson) and were growvn to confluence. When the
effect of test substances was examined, the cells were preincu-
bated for 24 hours in DME/Fl 2 supplemented with 0.3%
bovine serum albumin (BSA), 50 ,tg gentamicin. and 2 U/n-iL
nvstatin. Stock solutions were made of EGF and forskolin
(Signa) and IGF-l (a gift fron the Eli Lilly Research Labora-
tories, Indianapolis. IN), and aliquots were added to the cul-
tured cells. All experiments were repeated at least three timnes.
and representative results from a single experiment are pre-
sented.
RNA Extraction, Northern Blot,
and Hybridization
Total RNA was extracted using the procedure of Chomiczyn-
ski and Sacchii. Briefly. 2 mol/L sodium acetate, pH 4.0, was
added to cell lysates and extracted with water-saturated phenol
and chlorofornii:isoamyl alcohol (49:1). RNA was precipitated
-with one volume of isopropyl alcohol and was quantified
spectrophotometrically. Total RNA was separated by electro-
phoresis in a 1.2% agarose gel containing 3% formnaldehyde,
blotted to a nitrocellulose membrane (Millipore, Bedford,
MA) using lOX standard saline citrate (SSC), pH 7.0, and
ultraviolet-crosslinked with 1 2 mJ in a UV-Stratalinker (Strat-
agene, LaJolla. CA).1" Northern blots were prehybridized in a
solution containing 1 X Denhardt's, 10( mL 20X saline sodium
phosphate ethylenediaminetetra-acetic acid. 20 imL deionized
formnamide. and 10(0 pg/iiiL salmon sperm V)NA. Comple-
mentary DNA probes (a Bluescript plasmid containing the
PTP1I) insert; a generous gift from D)r. Mohanmnmed Adam,
Merck-Frosst Centre, Quebec, Canada) were radiolabeled us-
ing [a- 1)]PdCTIl (ICN, Costa Mesa, CA) and the randomn
primed labeling procedure outlined by Feinberg and Vo-
gelstein." After hybridization overnight in fresh buffer (Hy-
bridizer 700; Stratagene) at 37CG the blots were washed twice
with 2X SSC, 0.1% sodium dodecyl sulfate (Sl)S) at room




Figure 1. Presence of PTP1D) in the human endometrial carcinonia
cell line HEC-I-A. HEC-1-A cells were grown to confluence in a
1 (MI-mnm culture dish and were serum1 starved for 24 hours. Cells were
harvested, total RNA was extracted, and Northern blot hybridization
wvas performed. The PTP1Dni) NA was present in relative abun-
danle anid corresponds with a previously reported transcript of 6.8 kb.
at room temperature, and once with 0.1 X SSC at 50C for 6(0
minutes. The blots were exposed to Kodak XAR film at
-80C for 4 days. In a similar fashion. all blots were stripped by
nnsing in boiling water for 15 minutes and were hybridized
with a 1 .0-kb P-actin cDNA probe. Autoradiogranis were
scanned (Scanjet IlC; Hewlett Packard. Palo Alto, CA) using
an NIH viewer program (Shareware; National Institutes of
Health), and bands were quantified in arbitrary densitonmetric
un1its.
RESULTS
Initial experiments were conducted to determine the expres-
sion of PTPIl) in the endometnial carcinoma cell line HEC-
1 -A under basal conditions. Cells were grown to confluence in
a 1 00-mm dish with lDME/F12 and 10% FBS. Cells were
serum-starved for 24 hours and total RNA was extracted,
separated on an agarose gel, and hybridized with the l'TPl11)
probe as described earlier. The purpose of preincubation in
serumi-free mediumI was to exclude the possible stimulatory
effect ofgrowth factors associated with the serum to determine
whether PT1lI) was expressed uender basal conditions. Figure
I demonstrates the presence of a 6.8-kb transcript in this
endometrial carcinoma cell line, which corresponds to PTPI 1)
}RNA.
After establishing the expression of PTP1 D nmlkNA, we
conducted further experiments to detemine whether growth
factors are capable of regulating PTPI I) mRNA expression in
endometrial carcinoma. For tinme-course studies, HEC-1-A
cells were subcultured in five 1(( -nmm tissue culture dishes and
grown to confluence. After 24 hours of preiricubation, the
media were replaced with fresh, serum-free media. Forskolin
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Figure 2. Effects of time of exposure of EGF on PTP1D mRNA expression. HEC-I-A cells were grown to confluence in 100-mm culture
dishes and were serurm starxed for 24 hours. Media were replaced with fresh lDME/F12 containing 0.3% BSA, and EGF was added (final
concentration 10 ng/mL) and incubated for 24 hours. Cells were harvested at intervals of 0. 1, 3, 6, and 24 hours, total RNA was extracted,
and Northern hybridization was performed by using PTP1D cDNA probe. Hybridization bands were quantified from autoradiograms ill
densitoinetnc units and were normalized to actin. The ordinate represents the ratio of PTP1D niRNA to actin niRNA. PTP11) = protein
tyrosine phosphatase ID.
was added to four tissue culture dishes to a final concentration
of 10 pLmol/L. Cells were lysed, and total RNA was extracted
at 0, 1, 3, 6, and 24 hours after treatment with forskolin.
Similar experiments were performed with EGF (10 ng/mL).
Figures 2-4 demonstrate that the stimulatorv effect of these
mitogens on PTPIIJ mRNA expression was time dependent.
Specifically, forskolin induced maximal expression ofmRNA








baseline by 24 hours. The peak PTP1D mRNA response
occurred at 3-6 hours for both EGF and IGF-I.
To characterize further the regulation of PTP1D mRNA
expression in this endometrial carcinoma, we subcultured
HEC-1-A cells in a senies of six 100-mm tissue culture dishes,
grew them to confluence, and incubated them with increasing
doses (1, 5, 10, 20, and 30 pLmol/L) of forskolin for 6 hours.
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Figure 3. Effects of time of exposure of IGF-I on PTP1D mRNA expression. HEC-1-A cells were grown to confluence in 100-mim culture
dishes and were serum starved for 24 hours. Media were replaced with fresh DME/F12 containing 0.3% BSA, and IGF-I was added (final con-
centration 10() ng/niL) arid incubated for 24 hours. Cells were harvested at intervals of 0, 1, 3, 6, and 24 hours, total RNA was extracted, and
Northern hybridization was performed by using PTPlD EDNA probe. Hybridization bands were quanrtified froin autoradiogranis in den-
sitomrictnc units arid were nonmalized to actien. The ordinate represents the ratio of PTP1D niRNA to actin niRNA. Abbreviation as in Figure 2.
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Figure 4. Effects oftime ofexposure of forskolin on PTP1D rnRNA expression. HEC-1-A cells were grown to confluence in 100-mm culture
dishes and were serum starved for 24 hours. Media were replaced with fresh DME/F12 containing 0.3% BSA, and forskolin was added (final con-
centration 10 jimol/L) and incubated for 24 hours. Cells were harvested at intervals of 0, 1, 3, 6, and 24 hours, total RNA was extracted, and
Northern hybbndization was performed by using PTPID cDNA probe. Hybridization bands were quantified from autoradiogramls in den-
sitonmetnc units and were normalized to actin. The ordinate represents the ratio of PTP1D miRNA to actin mRNA. Abbreviation as in Figure 2.
using a [32P]-labeled PTP1D cDNA probe. Figure 5 demon-
strates that the effect of forskolin on PTP1D mRNA expres-
sion was dose dependent. The dose responses of EGF and
1GF-l were not tested because our previous studies7'8 showed
that the selected doses of these growth factors stimulate mito-
genesis of HEC-1-A cells.
DISCUSSION
PTP1D is a nonmembrane, protein tyrosine phosphatase,that
contains two SH2 domains. PTPID, also known as SHPTP2,
Syp, PTP2C, and SHPTP3, is a ubiquitously expressed protein
that is homologous to the Drosophila gene product corkscrew
(csw).'2 In mammalian cells, the gene encodes a 6.8-kb mes-
sage, which in turn translates into a 68-kDa protein,2 4 the full
function of which is still being elucidated. However, recent













factor-timulated mitogenesis,6 serving as an adapter between
receptor tyrosine kinases and the Grb-SOS complex.1 ' In
previous studies from our laboratory, we established that EGF,
the IGFs, insulin, and forskolin stimulate mitogenic activity of
the human endometrial cancer cells HEC-1-A and KLE.78 In
our effort to understand how the growth of endometrial car-
cinoma may be regulated by these growth factors, we exam-
ined the expression and inducibility of PTP1D in response to
EGF, IGF-I, and forskolin in HEC-l-A cells.
Our studies show that the endometrial carcinoma cell line
HEC-1-A expresses PTP1D mRNA with a transcript size
comparable to that reported in other cell types.2-4 The ex-
pression of PTP1D mRNA transcript was induced by EGF,
IGF-I, and forskolin in a time-dependent manner. The induc-
tion of the mRNA transcript in response to EGF, IGF-1, and
forskolin occurred at concentrations that have been shown to
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Figure 5. Effects of dose of forskolin on PTP1D riRNA expression. HEC-1-A cells were grown to confluence in 100--mm culture dishes and
were serum starved for 24 hours. Media were replaced with Fresh DME/F12 containing 0.3% BSA, and forskolin was added to a final
concentration of 1, 5, 10, 20, or 30 4umol/L and incubated for 6 hours. Cells were harvested, total RNA was extracted, and Northern
hybridization was performed by using PTP1 D cDNA probe. Hybridization bands were quantified from autoradiograms in densitometric units
and were normalized to actin. The ordinate represents the ratio of PTP11) inRNA to actin mRNA. Abbreviation as in Figure 2.
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stimulate nmitogenesis.7'8 Although we have not detenrined
whether the effect of these stimulatory agents on PTP1LD
nmRNA is due to increased gene expression or decreased
degradation of the transcript, the present studies implicate
PTPII) as a probable intermediate in growth factor-mediated
miltogenesis.
During hyperplasia and carcinogenesis, the proliferative and
differentiating activity of the endometriun becomes deregu-
lated and endometrial cells progress to stages of rapid growth,
inmmortalization, invasiveness, metastasis, and angiogenesis. In-
sulinz-like growth factor-I, a tyrosine kinase receptor, has been
shown to be a key factor involved in the phenotypic transfor-
mation of various cell types. Sell et a]14 showed that simian
virus 40) large antigen wvas unable to transformi- mouse embry-
onic fibroblasts that lacked the IGF-I receptor. Similarly, the
ability of the IGF-I receptor to facilitate the transforming
capacity of the EGF receptor was demonstrated in wild-type
mouse embryo cells. Coppola et al'ps showed that when the
EGF receptor expression plasmid was overexpressed in cells
derived front littermate embryos that had the IGF-I receptor
genes disrupted, those cells were resistant to transformation
despite reintroduction of the wild-type 1GF-I receptor. Other
studies from our laboratory have further demonstrated that the
IGF-I receptor is highly expressed in neoplastic endometrium.'6
The current studies also support the hypothesis that signaling
pathways are not isolated front each other, but converge to
produce "crosstalk" and activate a series of events that result in
cell proliferation and possibly malignancy. Our laboratory has
shown that the mitogenic response of the endometrial adeno-
carcinoma cell line HEC-1-A to IGF-I is enhanced wshen the
cells are preincubated with agents that increase intracellular
cAMP.' Other studies"7-- have shown that prostaglandins
increase cAMP accumulation in endonietrial cells. Thus, the
effects ofEGF and IGF-I in endometrial cell proliferation, and
possibly in malignant transfom ation, could be enhanced by
prostaglandins in vivo.
Insulin-like growth factor receptor substrate 1 has been
identified in different cell types, 22-2 as the mediator of IGF-1
action. One likely mechanisnm by which IRS-1 phosphoryla-
tion is enhanced may involve the action of protein tyrosine
phosphatases (PTPases). Studies by Kuhne et al5 and Milarski
and Saltiel,'3 have shown that upon activation of insulin re-
ceptor, IRS-I undergoes phosphorylation at multiple tyrosine
residues and forms a complex with PTP1 D. The IRS-I!
PTP1D complex further associates with Grb-SOS, leading to
the activation of ras-mediated mitogen-activated extracellular
signal regulated protein kinase kinase (mitogen-activated pro-
tein kinase kinase) phosphorylation, culminating in mitogen-
esis. Similarly, Xiao et al' and Rivard et al ' have shown that
when PTP1ID is blocked by either an anti-Syp antibody or an
inactive GST-SH2 protein, fibroblasts that have been serum
starved and then stimulated with EGF fail to proliferate.
The site of action of PTPID in niitogenic signaling is not
completely understood. Studies by Milarski and Saltiel 13
showed that expression of a catalytically inactive mutant of
PTPII) completely blocked stimulation of the MAP kinase
pathway by insulin as well as insulin-induced mitogenesis.
Tyrosine phosphorylation of the instilin receptor, or tyrosine
phosphorylation of IKS-1 or Shc, was not affected by the
expression of the dominant negative PTP1D.lA Evidence also
suggests that catalytically inactive PTP1ID does not interfere
with the binding of Grb2 to IRS-1 or formation of the
Shc-Grb2 complex.24 These studies suggest that PTP1D acts
downstream of initial phosphorylation leading to ras activation,
upstream of MAP kinase. Further studies by Sawada et a12l
have shown that catalytically inert PTPI I) blocked activation
of both MEK and raf-1 kinase by insulin, suggesting that
IPTP1 D might exert its growth-pronmoting effect by acting at a
step downstreamn of p21 ra. On the basis of our studies, we
conclude that the mitogenic stimulation of HEC-1-A cells by
EGF, lGF-I, and forskolin niay be mediated by induction of
PTPl[). PTP1 1), in turn, may exert its effect on mitogenesis
by acting at a step either upstream or downstream of p21
Our studies suggest that PTP1I) may play a crucial role in
the mitogenic stimulation of HEC-1-A cells by EGF, lGF-I,
and forskolin. The finding that PTP1D mRNA may be in-
duced by forskolin is a novel obsenration not described previ-
ously. Although the involvement of PTP1D in the mitogenic
signaling pathways of EGF and IGF-l in this endometrial
carcinoma cell line needs to be substantiated with further
experimental work, its inducibility by these peptide growth
factors and substances that increase intracellular cAMP levels
further supports its involvemnent in nmitogenesis. Further eval-
uation of PTP1D) is necessary to elucidate its precise function
in the malignant traisfornmation of endometrial cells.
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